Gismondo M R, Lo Bue A M, Chisari G, Pecorella G, Malandrino G, Petralito E
Istituto di Microbiologia, Università degli Studi di Catania.
Clin Ter. 1990 Jul 15;134(1):41-6.
The authors studied the ability of a live polymicrobial formulation containing Lactobacillus acidophilus 10(9) and Bifidobacterium bifidum 10(9) to act as an "ecological" therapy for gastritis and duodenitis. The study was carried out in volunteers suffering from these disorders which nowadays are attributed to C. pylori. The results obtained confirm previous findings in experimental animals. The polymicrobial formulation was found to be able to compete effectively with the microorganism responsible for the disorders and to improve the results obtained by traditional therapy.
作者研究了一种含有嗜酸乳杆菌10⁹和双歧双歧杆菌10⁹的活性多微生物制剂作为胃炎和十二指肠炎“生态”疗法的能力。该研究在患有这些目前归因于幽门螺杆菌的疾病的志愿者中进行。获得的结果证实了先前在实验动物中的发现。发现该多微生物制剂能够与引起这些疾病的微生物有效竞争，并改善传统疗法所取得的效果。
